Colorectal cancer prevention in ulcerative colitis: a case-control study.
about
Colorectal cancer and dysplasia in inflammatory bowel diseaseUlcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters CommitteeCancer in inflammatory bowel diseaseThe risk of colorectal cancer in ulcerative colitis: a meta-analysisAdvanced gastrointestinal endoscopic imaging for inflammatory bowel diseasesFrom the surface to the single cell: Novel endoscopic approaches in inflammatory bowel diseaseColitis-associated colon cancer: Is it in your genes?Ulcerative colitis-associated colorectal cancerDifferential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic aminesAdvanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped?Will a 5-ASA a day keep the cancer (and dysplasia) away?5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological studyReview article: the chemoprevention of colorectal carcinomaChemoprevention for colon cancer: new opportunities, fact or fiction?Chemoprevention of colorectal cancerRadical induction theory of ulcerative colitisReview article: maintenance therapy in patients with ulcerative colitisBCL-3 expression promotes colorectal tumorigenesis through activation of AKT signallingColorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease.Functional comparison between genes dysregulated in ulcerative colitis and colorectal carcinoma.In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitisIndications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Colorectal cancer complicating ulcerative colitis: a review.Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease.Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidencesUlcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?Cancer surveillance strategies in ulcerative colitis: the need for modernization.Current management of inflammatory bowel disease and colorectal cancer.Colorectal neoplasia in ulcerative colitis-recent advances.DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic targetColitis and colorectal cancer.Colorectal cancer surveillance in inflammatory bowel disease: A critical analysisRisk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study.Colorectal cancer in inflammatory bowel disease.Overcoming adherence issues in ulcerative colitis.Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid.The gut microbiome modulates colon tumorigenesisPros and cons of medical management of ulcerative colitis.
P2860
Q22241218-0F37A6B9-EE67-43F4-84FB-F69C6AC8E3DBQ22242348-0F2B3141-736B-4C99-8DA9-E5869EF195CCQ24648315-27D366B3-5FBA-40B1-9615-3E105AA92D1EQ24669747-152A1ED1-3389-4207-80CE-7111FCAD938EQ26774485-4B944525-772F-415B-AEC0-7588390C2AB6Q26777552-0F989690-EFA5-4A38-BA60-038C1D3840BCQ26778018-46962096-1787-4F02-AED8-DD4AABBCA4EAQ26822499-C9CFECF7-E9A4-4D1A-BBAD-0D7EF64C3431Q26864562-867368DF-EB4F-4BBC-9A37-9D4E1596C926Q26865465-B4515199-5826-4B35-BE68-54BC8054217EQ28176307-6F694D39-76F1-4A0D-8528-7AE4E899E7C8Q28182523-92500447-B3EF-4E57-8FEF-5366DFA2ABF1Q28212414-DAE727B3-8727-44D0-A1BE-E6159FB25229Q28219247-9DA292B2-9692-4B84-B405-BFC14A95E777Q28222931-593CA7AE-FE06-454A-9017-47C0980A0058Q28245348-CC48A6A3-7EE4-4E23-8D70-D674A6DE7099Q28260710-F4BBD209-1F51-4DFD-8F11-EBBA83DF6E65Q28596448-8E4C34BE-566B-4780-9ED3-ED93BA6E018CQ30245054-FA42D326-D293-4FF6-93A1-7FB564A66C34Q30651444-C64D4CF8-8AAB-4696-8F42-A00342D04788Q30822060-F2C65A5C-D675-4F46-B36F-F1C632A50DF9Q31132086-B029C23B-6840-416F-9B22-60C8BDD0A561Q33786357-40C5297C-4373-4F8D-81B5-B6CA8C056FF1Q33868970-A9DBA9BA-8B08-4379-BC7F-A2D815B3EE4CQ34070412-FC05D83A-8082-43F9-A439-13B08DC3A2CEQ34088621-193DE26B-D1ED-41D4-91C3-887DE5C6F02CQ34131254-378710C0-76CF-4513-B429-D8867E75A81EQ34137246-0A175C60-F7F0-43C5-83BC-112EB8F68E02Q34150651-8982C839-FE53-4624-8331-734F769F7A6FQ34192660-242BFE31-DE36-4BF4-B6FD-1B426B4C619AQ34352889-BE3DDADA-1E23-4165-A846-8B079D14AFC4Q34412280-A4D9E02D-36C1-4D47-8A87-0E0418E62D7FQ34459879-0A2213C1-6EC0-416C-B9C1-2D9F0FBCFA72Q34508778-B777A0E4-BD5F-4D2D-BDAE-3F23EE424143Q34565612-B7F81DDF-A7BA-47C8-B66D-91A508E817E4Q34619754-97569051-C2D6-4AF0-84AA-03338252FB7CQ35013898-BB2C642A-5A6E-43DC-AF99-AC5CAC90C67EQ35024521-A816D39E-8E81-4BAD-9869-D6B555BB919CQ35032207-61953300-4169-4F09-9F21-9D9C659BBAD4Q35100726-CADFAE0F-330C-4460-980F-20819C9EE59D
P2860
Colorectal cancer prevention in ulcerative colitis: a case-control study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Colorectal cancer prevention in ulcerative colitis: a case-control study.
@en
type
label
Colorectal cancer prevention in ulcerative colitis: a case-control study.
@en
prefLabel
Colorectal cancer prevention in ulcerative colitis: a case-control study.
@en
P2093
P2860
P1476
Colorectal cancer prevention in ulcerative colitis: a case-control study
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2000.00698.X
P407
P577
2000-02-01T00:00:00Z